NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Prenosis

Prenosis

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://prenosis.com/

Last Round

Grant

Jan 29, 2026

Total Funding Raised

$55.85M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Prenosis is a healthcare technology company that develops integrated diagnostics and therapeutics for critical care conditions using artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Medical Devices

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

sepsis diagnosisAI diagnostic softwareclinical decision supportsepsis risk assessmentmedical AIEHR integrationprecision medicinediagnostic algorithmhealth techdigital healthhealthcare analyticspredictive diagnosticsclinical workflow automationAI in healthcareSaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prenosis Comps

Public and private peers based on sector, stage, and business model.

Prenosis comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Prenosis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 29, 2026
Series AJan 29, 2024
GrantJul 12, 2023
GrantJun 7, 2023
VC RoundMar 9, 2022
Grant
Nov 17, 2021

Key People

Founding team and executive leadership

Angela Thomas

Chief Financial Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 29, 2026

    $20M raised in grant funding.

  • Dec 19, 2025

    Received the inaugural UL Enterprise Safety Science Award for Sepsis ImmunoScore.

Prenosis Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prenosis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prenosis's valuation, stock price, and market status.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range44
Year Founded2014
Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.